Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy update 1994]

K P Maier1

  • 1Fachbereich Gastroenterologie, Medizinischen Klinik, Städtischen Krankenanstalten Esslingen.

Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|September 6, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron, HCV and the liver.

World journal of gastroenterology·2016
Same author

[Are there therapeutic approaches of non-alcoholic fatty liver disease and its complications?].

Der Internist·2008
Same author

[Ascites].

Praxis·2008
Same author

[Non-alcoholic steatohepatitis--a new epidemic].

Praxis·2007
Same author

[Diverticulosis--diverticulitis].

Praxis·2007
Same author

[Non-alcoholic liver disease (NASH)].

Praxis·2006
Same journal

[In Process Citation]

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1999
Same journal

[A case from practice (306). Erythema (chronicum) migrans (stage I of Lyme borreliosis].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[A case from practice (305). Recurrent erysipelas--tinea pedis et unginum--chronic venous insufficiency].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Neuroendocrine tumors of the stomach (stomach carcinoid)].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
Same journal

[Mental suffering IN patients with parkinsonism].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis·1994
See all related articles

Alpha-interferon (IFN) treatment can reduce viral replication in select patients with hepatitis B and C. However, its effectiveness is limited for hepatitis D and not recommended for high-risk groups.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Context:

  • Viral hepatitis B, C, and D are significant global health concerns.
  • Alpha-interferon (IFN) is an established antiviral therapy.
  • Treatment efficacy varies significantly across different hepatitis virus types.

Purpose:

  • To evaluate the efficacy of alpha-interferon (IFN) in treating chronic viral hepatitis.
  • To assess treatment outcomes in patients with hepatitis B, C, and D.
  • To identify patient populations where IFN therapy is not recommended.

Summary:

  • IFN treatment reduces viral replication in selected patients with chronic hepatitis B, achieving HBeAg clearance in approximately 40%.
  • About 25% of chronic hepatitis C patients benefit from long-term (6-12 months) IFN therapy.

Related Experiment Videos

  • Hepatitis D treatment with IFN is largely unsatisfactory, with <10% viral clearance even after one year.

    • Impact:

    • IFN therapy offers a viable treatment option for some chronic hepatitis B and C patients.
    • Current IFN protocols show limited success for chronic hepatitis D.
    • IFN is contraindicated in high-risk patients, including those post-transplant or on immunosuppressive/hemodialysis therapy, due to insufficient data.